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Chorioangioma is a benign angioma of placenta arising from chorionic tissue. Large chorioangioma has unfavourable eﬀects on
both mother and fetus. We describe a case with large chorioangioma that had a poor outcome on the fetus. We also reviewed the
literature on prognostic factors aﬀecting fetal outcome.
1.Introduction
Chronic placental insuﬃciency is the commonest cause for
fetal growth restriction. Rare placental causes aﬀecting fetal
outcome are partial mole, chorioangioma, and placental
teratoma. Large chorioangioma has adverse eﬀects on both





who were born vaginally presented to us at 32 weeks gesta-
tion with history of gradual abdominal distension and vague
pain abdomen since one month. On examination, blood
pressure was 130/80mmHg, abdomen was overdistended
upto xiphisternum, fetal parts were not palpable, and fetal
heart sounds could not be localized. She was neither diabetic
nor anemic.
Ultrasound showed a single live fetus corresponding to
32weeks of gestation with polyhydramnios (AFI: 28cm).
Normal amniotic ﬂuid index ranges from 8 to 20cm. There
were no gross structural abnormalities. Placenta was on
the anterior wall upper segment, grade II. A well-deﬁned
echogenic mass measuring 11.5cm × 12cm diﬀerent from
the rest of the placenta was seen bulging on the fetal side
(Figure 1). Patient went into spontaneous preterm labor and
delivered female baby weighing 1.6Kg with Apgar scores 9
and 10 at 1 and 5minutes, respectively. Placenta weighed
2Kg. A lobular mass measuring 12cm × 12cm was attached
to the fetal surface of placenta with a pedicle (Figure 2). Baby
died of DICon 3rdpostnatal day. Histopathology ofplacenta
was angiomatous pattern of chorioangioma (Figure 3).
3. Discussion
3.1. Pathogenesis and Pathology. Placental chorioangioma is
the most common benign tumor of the placenta. The largest
retrospective study of 22000 placental examinations showed
138chorioangioma with an incidence of 0.6% [1]. Theywere
more seen in multiple pregnancies and in female babies.
Chorioangioma is believed to arise by 16th day of fertiliza-
tion, although there is no documentation of tumor in ﬁrst
trimester [2]. It consists of a benign angioma arising from
chorionic tissue. Three histological patterns of chorioan-
giomas have been described by Marchetti [3]( Figure 3):
angiomatous, cellular, and degenerate. The angiomatous is
the most common, with numerous small areas of endothelial
tissue, capillaries, and blood vessels surrounded by placental
stroma.These lesions are sometimes classiﬁed as placental
hamartomas rather than true neoplasia. [1]. There is no
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Figure 1:Transabdominalultrasoundshowingechogeniclargelob-
ular mass suggestive of chorioangioma measuring approximately
12 × 12cm, arrow pointing to tumor.
Figure 2: A huge highly vascular tumor suggestive of chorioan-
gioma with placenta weighing 2kg after delivery, arrow pointing to
tumor.
3.2. Clinical Features and Complications. Tumors of less
than 5cm are usually asymptomatic and unlikely to cause
maternal and fetal complications. Large tumors probably act
as arteriovenous shunts and cause complications. Maternal
complications are preeclampsia, preterm labour, placental
abruption,a n dpolyhydramnios. Of the various reported clin-
ical complications, the correlation of chorioangioma with
hydramnios and preterm delivery is signiﬁcant, latter being
a sequelae of the hydramnios. Fetal congestive heart failure
may develop because of the increased blood ﬂow through the
low resistance vascular channels in the chorioangioma acting
as an arteriovenous shunt. Other associated complications
Figure 3: Microscopic examination of chorioangioma with lakes of
blood vessels suggestive of angiomatous pattern, arrow indicating
vessels.
are hydrops, hemolytic anemia, congenital anomalies, fetal
thrombocytopenia, cardiomegaly,a n dgrowth restriction.
3.3. Ultrasound Diagnosis. Clarke in 1978 described the
ﬁrst case of chorioangioma [4]. Antenatal ultrasound was
reported in 1978, and this has made diagnosis and follow
up possible before delivery [2]. This also helps in close fetal
monitoring and hence timely delivery. Gray-scale ﬁndings
are well-deﬁned complex echogenic mass diﬀerent from the
rest of placenta and tumor protrudes into amniotic cavity
near umbilical cord insertion. Use of Doppler to diﬀerentiate
from placental teratoma, blood clot, and leiomyoma was
ﬁrst demonstrated by Bromley and Benacerraﬀ [5]. On
Doppler, feeding vessel usually has same pulsatile ﬂow as
that of umbilical artery but may have arteriovenous shunt
causing low resistance ﬂow [6]. Unfortunately, we could not
do Doppler in our case due to lack of facilities. Even MRI
has been done in tumors that look similar to myoma in
ultrasound.T2imagesofMRIwillbesimilartohemangioma
and hence diagnosis is possible [7].
3.4. Interventions. Chorioangioma with complications be-
fore fetal viability requires interventions. Various techniques
with varying success rates have been tried such as serial
fetal transfusions [8], fetoscopic laser coagulation of vessels
supplying the tumor [9], chemosclerosis with absolute
alcohol [10], and endoscopic surgical devasculari-zation.
Polyhydramnios is treated with therapeutic amniocentesis
and maternal indomethacin therapy. Steroid administration
for acceleration of fetal lung maturity before 34weeks is
indicated. However, our patient was an unbooked case and
delivered within 48hours of admission.
3.5. Prognostic Factors. Large chorioangioma associated with
polyhydramnios leads to high perinatal morbidity andCase Reports in Obstetrics and Gynecology 3
mortality, like in this case. Postpartum hemorrhage is a well-
known complication in mother.
3.6. Diﬀerential Diagnosis. Chorioangioma is often confused
with placental teratoma, degenerated myoma, and blood
clot. Chorioangioma is diﬀerentiated from the rest by
demonstration of vascular channels similar to fetal vessels.
Echo pattern of blood clot diﬀers with time, while chorioan-
gioma remains same. Partial mole has diﬀuse pattern and
m y o m ai ss e e ni nm a t e r n a ls u r f a c e[ 2].
4. Conclusion
High fetal death in a case of large chorioangioma warrants
institutional and timely delivery as seen in our case. Ante-
natal diagnosis is by ultrasound, and Doppler would have
been the investigation of choice in accurate diagnosis of
chorioangioma. Regular followup helps in timely diagnosis
and intervention.
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